Cargando…

MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation

Previous cDNA microarray results showed that MYH9 gene expression levels are increased in TGF-β1-stimulated lung fibroblast. Recently, our proteomic results revealed that the expression levels of MYH9 protein are notably upregulated in lung tissues of bleomycin-treated rats. However, whether MYH9 pl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xionghua, Zhu, Mei, Chen, Xihua, Jiang, Xiaogang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838063/
https://www.ncbi.nlm.nih.gov/pubmed/33519439
http://dx.doi.org/10.3389/fphar.2020.573524
_version_ 1783643087932751872
author Sun, Xionghua
Zhu, Mei
Chen, Xihua
Jiang, Xiaogang
author_facet Sun, Xionghua
Zhu, Mei
Chen, Xihua
Jiang, Xiaogang
author_sort Sun, Xionghua
collection PubMed
description Previous cDNA microarray results showed that MYH9 gene expression levels are increased in TGF-β1-stimulated lung fibroblast. Recently, our proteomic results revealed that the expression levels of MYH9 protein are notably upregulated in lung tissues of bleomycin-treated rats. However, whether MYH9 plays a critical role in the differentiation of fibroblast remains unclear. Herein, we demonstrated that TGF-β1 increased MYH9 expression, and siRNA-mediated knockdown of MYH9 and pharmacological inhibition of MYH9 ATPase activity remarkably repressed TGF-β1-induced lung fibroblast-to-myofibroblast differentiation. TGF-β1-stimulated MYH9 induction might be via ALK5/Smad2/3 pathway but not through noncanonical pathways, including p38 mitogen-activated kinase, and Akt pathways in lung fibroblasts. Our results showed that MYH9 inhibition suppressed TGF-β1-induced lung fibroblast-to-myofibroblast differentiation, which provides valuable information for illuminating the pathological mechanisms of lung fibroblast differentiation, and gives clues for finding new potential target for pulmonary fibrosis treatment.
format Online
Article
Text
id pubmed-7838063
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78380632021-01-28 MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation Sun, Xionghua Zhu, Mei Chen, Xihua Jiang, Xiaogang Front Pharmacol Pharmacology Previous cDNA microarray results showed that MYH9 gene expression levels are increased in TGF-β1-stimulated lung fibroblast. Recently, our proteomic results revealed that the expression levels of MYH9 protein are notably upregulated in lung tissues of bleomycin-treated rats. However, whether MYH9 plays a critical role in the differentiation of fibroblast remains unclear. Herein, we demonstrated that TGF-β1 increased MYH9 expression, and siRNA-mediated knockdown of MYH9 and pharmacological inhibition of MYH9 ATPase activity remarkably repressed TGF-β1-induced lung fibroblast-to-myofibroblast differentiation. TGF-β1-stimulated MYH9 induction might be via ALK5/Smad2/3 pathway but not through noncanonical pathways, including p38 mitogen-activated kinase, and Akt pathways in lung fibroblasts. Our results showed that MYH9 inhibition suppressed TGF-β1-induced lung fibroblast-to-myofibroblast differentiation, which provides valuable information for illuminating the pathological mechanisms of lung fibroblast differentiation, and gives clues for finding new potential target for pulmonary fibrosis treatment. Frontiers Media S.A. 2021-01-13 /pmc/articles/PMC7838063/ /pubmed/33519439 http://dx.doi.org/10.3389/fphar.2020.573524 Text en Copyright © 2021 Sun, Zhu, Chen and Jiang. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Sun, Xionghua
Zhu, Mei
Chen, Xihua
Jiang, Xiaogang
MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation
title MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation
title_full MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation
title_fullStr MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation
title_full_unstemmed MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation
title_short MYH9 Inhibition Suppresses TGF-β1-Stimulated Lung Fibroblast-to-Myofibroblast Differentiation
title_sort myh9 inhibition suppresses tgf-β1-stimulated lung fibroblast-to-myofibroblast differentiation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7838063/
https://www.ncbi.nlm.nih.gov/pubmed/33519439
http://dx.doi.org/10.3389/fphar.2020.573524
work_keys_str_mv AT sunxionghua myh9inhibitionsuppressestgfb1stimulatedlungfibroblasttomyofibroblastdifferentiation
AT zhumei myh9inhibitionsuppressestgfb1stimulatedlungfibroblasttomyofibroblastdifferentiation
AT chenxihua myh9inhibitionsuppressestgfb1stimulatedlungfibroblasttomyofibroblastdifferentiation
AT jiangxiaogang myh9inhibitionsuppressestgfb1stimulatedlungfibroblasttomyofibroblastdifferentiation